Part 3.8 / M22, M23, M29

Catalogusnummer

►M18  Chemische naam ◄

EG-nr.

CAS-nr.

Indeling

Etikettering

►M18  Specifieke concentratiegrenzen, M-factoren en ATE's (*1)  ◄

Opmerkingen

Gevarenklasse en

-categorie

Gevarenaanduiding

Pictogram, signaalwoord

Gevarenaanduiding

Aanvullende gevarenaanduiding

▼M16

006-069-00-3

thiofanaat-methyl (ISO);

dimethyl(1,2-fenyleendicarbamothioyl)biscarbamaat;

dimethyl 4,4′-(o-fenyleen)bis(3-thioallofanaat)

245-740-7

23564-05-8

Carc. 2

Muta. 2

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H341

H332

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H341

H332

H317

H410

inademing: ATE = 1,7 mg/l

(stofdeeltjes en nevels)

M = 10

M = 10

006-076-00-1

mancozeb (ISO); mangaanethyleenbis(dithiocarbamaat)(polymeer)complex met zinkzout

—

8018-01-7

Carc. 2

Repr. 1B

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H360D

H373 (schildklier, zenuwstelsel)

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H373 (schildklier, zenuwstelsel)

H317

H410

M = 10

M = 10

007-004-00-1

salpeterzuur … % [C > 70 %]

231-714-2

7697-37-2

Ox. Liq. 2

Acute Tox. 1

Skin Corr. 1A

H272

H330

H314

GHS03

GHS06

GHS05

Dgr

H272

H330

H314

EUH071

Ox. Liq. 2; H272: C ≥ 99 %

Ox. Liq. 3; H272: 70 % ≤ C < 99 %

B

007-030-00-3

salpeterzuur … % [C ≤ 70 %]

231-714-2

7697-37-2

Ox. Liq. 3

Acute Tox. 3

Skin Corr. 1A

H272

H331

H314

GHS03

GHS06

GHS05

Dgr

H272

H331

H314

EUH071

Ox. Liq. 3; H272: C ≥ 65 %

inademing: ATE = 2,65 mg/l (dampen)

Skin Corr. 1A; H314: C ≥ 20 %

Skin Corr. 1B; H314: 5 % ≤ C < 20 %

B

014-018-00-1

octamethylcyclotetrasiloxaan;

[D4]

209-136-7

556-67-2

Repr. 2

Aquatic Chronic 1

H361f ***

H410

GHS08

GHS09

Wng

H361f ***

H410

M = 10

014-048-00-5

vezels bestaande uit siliciumcarbide (met diameter < 3 μm, lengte > 5 μm en dimensieverhouding ≥ 3:1)

206-991-8

409-21-2

308076-74-6

Carc. 1B

H350i

GHS08

Dgr

H350i

014-049-00-0

trimethoxyvinylsilaan; trimethoxy(vinyl)silaan

220-449-8

2768-02-7

Skin Sens. 1B

H317

GHS07

Wng

H317

014-050-00-6

tris(2-methoxyethoxy)vinylsilaan;

6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaündecaan;

213-934-0

1067-53-4

Repr. 1B

H360FD

GHS08

Dgr

H360FD

015-113-00-0

tolclofos-methyl (ISO);

O-(2,6-dichloor-p-tolyl) O,O-dimethylthiofosfaat

260-515-3

57018-04-9

Skin Sens. 1B

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 1

M = 1

015-134-00-5

pirimifos-methyl (ISO);

O-(2-diëthylamino-6-methylpyrimidine-4-yl)-O,O-dimethylthiofosfaat

249-528-5

29232-93-7

Acute Tox. 4

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H372 (zenuwstelsel)

H400

H410

GHS07

GHS08

GHS09

Dgr

H302

H372 (zenuwstelsel)

H410

oraal: ATE = 1414 mg/kg lichaamsgewicht

M = 1000

M = 1000

015-181-00-1

fosfine

232-260-8

7803-51-2

Flam. Gas 1

Press. Gas

Acute Tox. 1

Skin Corr. 1B

Aquatic Acute 1

H220

H330

H314

H400

GHS02

GHS04

GHS06

GHS05

GHS09

Dgr

H220

H330

H314

H400

inademing:

ATE = 10 ppmV (gassen)

U

015-189-00-5

fenylbis(2,4,6-trimethylbenzoyl)-fosfineoxide

423-340-5

162881-26-7

Skin Sens. 1A

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

016-098-00-3

dimethyldisulfide

210-871-0

624-92-0

Flam. Liq. 2

Acute Tox. 3

Acute Tox. 3

STOT SE 3

STOT SE 1

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H225

H331

H301

H336

H370 (bovenste luchtwegen, inademing)

H319

H317

H400

H410

GHS02

GHS06

GHS08

GHS09

Dgr

H225

H331

H301

H336

H370 (bovenste luchtwegen, inademing)

H319

H317

H410

inademing: ATE = 5 mg/l (dampen)

oraal: ATE = 190 mg/kg lichaamsgewicht

M = 1

M = 10

►C12  022-006-00-2 ◄

titaniumdioxide;

[in poedervorm, bevattend: 1 % of meer deeltjes met een aërodynamische diameter ≤ 10 μm]

236-675-5

13463-67-7

Carc. 2

H351 (inademing)

GHS08

Wng

H351 (inademing)

V, W, 10

027-001-00-9

kobalt

231-158-0

7440-48-4

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 4

H350

H341

H360F

H334

H317

H413

GHS08

Dgr

H350

H341

H360F

H334

H317

H413

028-007-00-4

trinikkeldisulfide;

nikkelsubsulfide; [1]

heazlewoodiet [2]

234-829-6 [1]

— [2]

12035-72-2 [1]

12035-71-1 [2]

Carc. 1A

Muta. 2

Acute Tox. 3

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H331

H372**

H317

H400

H410

GHS08

GHS06

GHS09

Dgr

H350i

H341

H331

H372**

H317

H410

inademing:

ATE = 0,92 mg/l

(stofdeeltjes of nevels)

028-018-00-4

nikkelbis(sulfamidaat);

nikkelsulfamaat

237-396-1

13770-89-3

Carc. 1A

Muta. 2

Repr. 1B

Acute Tox. 4

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H302

H372**

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D***

H302

H372**

H334

H317

H410

oraal: ATE = 853 mg/kg lichaamsgewicht (anhydraat)

oraal: ATE = 1 098 mg/kg lichaamsgewicht (tetrahydraat)

STOT RE 1;

H372: C ≥ 1 %

STOT RE 2;

H373: 0,1 % ≤ C < 1 %

Skin Sens. 1;

H317: C ≥ 0,01 %

M = 1

029-002-00-X

dikoperoxide;

koper(I)oxide

215-270-7

1317-39-1

Acute Tox. 4

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H332

H302

H318

H410

inademing: ATE = 3,34 mg/l (stofdeeltjes of nevels)

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 100

M = 10

029-015-00-0

koperthiocyanaat

214-183-1

1111-67-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

EUH032

M = 10

M = 10

029-016-00-6

koper(II)oxide

215-269-1

1317-38-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 100

M = 10

029-017-00-1

dikoperchloridetrihydroxide

215-572-9

1332-65-6

Acute Tox. 4

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H332

H301

H400

H410

GHS06

GHS09

Dgr

H332

H301

H410

inademing: ATE = 2,83 mg/l (stofdeeltjes of nevels)

oraal: ATE = 299 mg/kg lichaamsgewicht

M = 10

M = 10

029-018-00-7

tetrakoperhexahydroxidesulfaat; [1]

tetrakoperhexahydroxidesulfaathydraat [2]

215-582-3 [1]

215-582-3 [2]

1333-22-8 [1]

12527-76-3 [2]

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 10

M = 10

029-019-01-X

koperschilfers (gecoat met alifatisch zuur)

—

—

Acute Tox. 3

Acute Tox. 4

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H319

H400

H410

GHS06

GHS09

Dgr

H331

H302

H319

H410

inademing: ATE = 0,733 mg/l (stofdeeltjes of nevels)

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 10

M = 10

029-020-00-8

koper(II)carbonaat--koper(II)hydroxide (1:1)

235-113-6

12069-69-1

Acute Tox. 4

Acute Tox. 4

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H319

H400

H410

GHS07

GHS09

Wng

H332

H302

H319

H410

inademing: ATE = 1,2 mg/l (stofdeeltjes of nevels)

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 10

M = 10

029-021-00-3

koperdihydroxide;

koper(II)hydroxide

243-815-9

20427-59-2

Acute Tox. 2

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H318

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H302

H318

H410

inademing: ATE = 0,47 mg/l (stofdeeltjes of nevels)

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 10

M = 10

029-022-00-9

Bordeauxse pap;

reactieproducten van kopersulfaat met calciumdihydroxide

—

8011-63-0

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H332

H318

H410

inademing: ATE = 1,97 mg/l (stofdeeltjes of nevels)

M = 10

M = 1

029-023-00-4

kopersulfaat-pentahydraat

231-847-6

7758-99-8

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H302

H318

H410

oraal: ATE = 481 mg/kg lichaamsgewicht

M = 10

M = 1

029-024-00-X

gegranuleerd koper;

[lengte van de deeltjes: van 0,9 mm tot en met 6,0 mm; breedte van de deeltjes: van 0,494 tot en met 0,949 mm]

231-159-6

7440-50-8

Aquatic Chronic 2

H411

GHS09

H411

029-025-00-5

bis(N-hydroxy-N-nitrosocyclohexylaminato-O,O’)koper;

bis(N-cyclohexyldiazeniumdioxy)koper;

[Cu-HDO]

239-703-4

312600-89-8

15627-09-5

Flam. Sol. 1

Acute Tox. 4

STOT RE 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H228

H302

H373 (lever)

H318

H400

H410

GHS02

GHS07

GHS08

GHS05

GHS09

Dgr

H228

H302

H373 (lever)

H318

H410

oraal: ATE = 360 mg/kg lichaamsgewicht

M = 1

M = 1

050-021-00-4

dichloordioctylstannaan

222-583-2

3542-36-7

Repr. 1B

Acute Tox. 2

STOT RE 1

Aquatic Chronic 3

H360D

H330

H372 **

H412

GHS08

GHS06

Dgr

H360D

H330

H372 **

H412

Repr. 1B; H360 D: C ≥ 0,03 %

inademing: ATE = 0,098 mg/l (stofdeeltjes of nevels)

050-027-00-7

2-ethylhexyl-10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoaat; [DOTE]

239-622-4

15571-58-1

Repr. 1B

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H372 (immuunsysteem)

H400

H410

GHS08

GHS09

Dgr

H360D

H372 (immuunsysteem)

H410

050-031-00-9

dioctyltindilauraat; [1]

stannaan, dioctyl-, bis(kokos-acyloxy)derivaten [2]

222-883-3 [1] 293-901-5 [2]

3648-18-8 [1] 91648-39-4 [2]

Repr. 1B

STOT RE 1

H360D

H372 (immuunsysteem)

GHS08

Dgr

H360D

H372 (immuunsysteem)

080-012-00-0

methylkwikchloride

204-064-2

115-09-3

Carc. 2

Repr. 1A

Lact.

Acute Tox. 2

Acute Tox. 2

Acute Tox. 2

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H360Df

H362

H330

H310

H300

H372 (zenuwstelsel, nieren)

H400

H410

GHS08

GHS06

GHS09

Dgr

H351

H360Df

H362

H330

H310

H300

H372 (zenuwstelsel, nieren)

H410

inademing: ATE = 0,05 mg/l (stofdeeltjes of nevel)

via de huid: ATE = 50 mg/kg lichaamsgewicht

oraal: ATE = 5 mg/kg lichaamsgewicht

1

601-029-00-7

dipenteen;

limoneen [1]

(S)-p-mentha-1,8-dieen; l-limoneen [2]

trans-1-methyl-4-(1-methylvinyl)cyclohexeen; [3]

(±)-1-methyl-4-(1-methylvinyl)cyclohexeen [4]

205-341-0 [1]

227-815-6 [2]

229-977-3 [3]

231-732-0 [4]

138-86-3 [1]

5989-54-8 [2]

6876-12-6 [3]

7705-14-8 [4]

Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H315

H317

H400

H410

GHS02

GHS07

GHS09

Wng

H226

H315

H317

H410

C

601-090-00-X

benzo[rst]pentafeen

205-877-5

189-55-9

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341

601-091-00-5

dibenzo[b,def]chryseen;

dibenzo[a,h]pyreen

205-878-0

189-64-0

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341

601-092-00-0

dibenzo[def,p]chryseen;

dibenzo[a,l]pyreen

205-886-4

191-30-0

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341

Carc. 1B; H350: C ≥ 0,001 %

601-093-00-6

1,4-dimethylnaftaleen

209-335-9

571-58-4

Acute Tox. 4

Asp. Tox. 1

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 3

H302

H304

H319

H400

H412

GHS07

GHS08

GHS09

Dgr

H302

H304

H319

H410

oraal: ATE = 1 300 mg/kg lichaamsgewicht

M = 1

601-094-00-1

1-isopropyl-4-methylbenzeen;

p-cymeen

202-796-7

99-87-6

Flam. Liq. 3

Acute Tox. 3

Asp. Tox. 1

Aquatic Chronic 2

H226

H331

H304

H411

GHS02

GHS06

GHS08

GHS09

Dgr

H226

H331

H304

H411

inademing: ATE = 3 mg/l (dampen)

601-095-00-7

p-menta-1,3-dieen; 1-isopropyl-4-methylcyclohexa-1,3-dieen;

alfa-terpineen

202-795-1

99-86-5

Flam. Liq. 3

Acute Tox. 4

Skin Sens. 1

Asp. Tox. 1

Aquatic Chronic 2

H226

H302

H317

H304

H411

GHS02

GHS07

GHS08

GHS09

Dgr

H226

H302

H317

H304

H411

oraal: ATE = 1 680 mg/kg lichaamsgewicht

601-096-00-2

(R)-p-mentha-1,8-diene;

d-limonene

227-813-5

5989-27-5

Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1B

Asp. Tox. 1

Aquatic Acute 1

Aquatic Chronic 3

H226

H315

H317

H304

H400

H412

GHS02

GHS07

GHS08

GHS09

Dgr

H226

H315

H317

H304

H410

M = 1

602-110-00-X

tetrafluorethyleen

204-126-9

116-14-3

Carc. 1B

H350

GHS08

Dgr

H350

603-023-00-X

ethyleenoxide;

oxiraan

200-849-9

75-21-8

Flam. Gas 1

Press. Gas

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 3

Acute Tox. 3

STOT SE 3

STOT SE 3

STOT RE 1

Skin Corr. 1

Eye Dam. 1

H220

H350

H340

H360Fd

H331

H301

H335

H336

H372 (zenuwstelsel)

H314

H318

GHS02

GHS08

GHS06

GHS05

Dgr

H220

H350

H340

H360Fd

H331

H301

H335

H336

H372 (zenuwstelsel)

H314

inademing: ATE = 700ppm (gassen)

oraal: ATE = 100 mg/kg lichaamsgewicht

U

603-024-00-5

1,4-dioxaan

204-661-8

123-91-1

Flam. Liq. 2

Carc. 1B

STOT SE 3

Eye Irrit. 2

H225

H350

H335

H319

GHS02

GHS08

GHS07

Dgr

H225

H350

H335

H319

EUH019

EUH066

D

603-065-00-9

m-bis(2,3-epoxypropoxy)benzeen;

resorcinoldiglycidylether

202-987-5

101-90-6

Carc. 1B

Muta. 2

Acute Tox. 3

Acute Tox. 4

Skin Irrit. 2

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H350

H341

H311

H302

H315

H319

H317

H412

GHS08

GHS06

Dgr

H350

H341

H311

H302

H315

H319

H317

H412

dermaal: ATE = 300 mg/kg lichaamsgewicht oraal: ATE = 500 mg/kg lichaamsgewicht

603-066-00-4

7-oxa-3-oxiranylbicyclo[4.1.0]heptaan; 1,2-epoxy-4-epoxyethylcyclohexaan; 4-vinylcyclohexeendiëpoxide

203-437-7

106-87-6

Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 3

Acute Tox. 4

H350

H341

H360F

H331

H302

GHS08

GHS06

Dgr

H350

H341

H360F

H331

H302

inademing: ATE = 0,5 mg/l (stofdeeltjes of nevels)

oraal: ATE = 1 847 mg/kg lichaamsgewicht

603-098-00-9

2-fenoxyethanol

204-589-7

122-99-6

Acute Tox. 4

STOT SE 3

Eye Dam. 1

H302

H335

H318

GHS05

GHS07

Dgr

H302

H335

H318

oraal:

ATE = 1 394 mg/kg lichaamsgewicht

603-236-00-8

ethanol, 2,2'-iminobis-, N-(C13-15-vertakt en lineair alkyl)-derivaten

308-208-6

97925-95-6

Repr. 1B

H360D

GHS08

Dgr

H360D

603-237-00-3

ipconazool (ISO);

(1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chloorbenzyl)-5-isopropyl-1-(1H-1,2,4-triazool-1-ylmethyl)cyclopentanol

—

125225-28-7

115850-69-6

115937-89-8

Repr. 1B

Acute Tox. 4

STOT RE 2

Aquatic Chronic 1

H360D

H302

H373 (ogen, huid, lever)

H410

GHS08

GHS07

GHS09

Dgr

H360D

H302

H373 (ogen, huid, lever)

H410

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 100

603-238-00-9

bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme

205-594-7

143-24-8

Repr. 1B

H360FD

GHS08

Dgr

H360FD

603-239-00-4

paclobutrazol (ISO);

(2RS,3RS)-1-(4-chloorfenyl)-4,4-dimethyl-2-(1H-1,2,4-triazool-1-yl)pentaan-3-ol

—

76738-62-0

Repr. 2

Acute Tox. 4

Acute Tox. 4

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H332

H302

H319

H400

H410

GHS08

GHS07

GHS09

Wng

H361d

H332

H302

H319

H410

inademing: ATE = 3,13 mg/l (stofdeeltjes of nevels)

oraal: ATE = 490 mg/kg lichaamsgewicht

M = 10

M = 10

603-240-00-X

2,2-bis(broommethyl)propaan-1,3-diol

221-967-7

3296-90-0

Carc. 1B

Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

603-241-00-5

geraniol;

(2E)-3,7-dimethylocta-2,6-dieen-1-ol

203-377-1

106-24-1

Skin Sens. 1

H317

GHS07

Wng

H317

604-095-00-5

6,6’-di-tert-butyl-2,2’-methyleendi-p-cresol;

[DBMC]

204-327-1

119-47-1

Repr. 1B

H360F

GHS08

Dgr

H360F

605-005-00-7

metaldehyde (ISO);

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacycloöctaan

203-600-2

108-62-3

Flam. Sol. 2

Repr. 2

Acute Tox. 3

Aquatic Chronic 3

H228

H361f

H301

H412

GHS02

GHS08

GHS06

Dgr

H228

H361f

H301

H412

oraal: ATE = 283 mg/kg lichaamsgewicht

605-041-00-3

2-(4-tert-butylbenzyl)propionaldehyde

201-289-8

80-54-6

Repr. 1B

H360Fd

GHS08

Dgr

H360Fd

606-004-00-4

4-methylpentaan-2-on; isobutylmethylketone

203-550-1

108-10-1

Flam. Liq. 2

Carc. 2

Acute Tox. 4

STOT SE 3

Eye Irrit. 2

H225

H351

H332

H336

H319

GHS02

GHS07

GHS08

Dgr

H225

H351

H332

H336

H319

EUH066

inademing: ATE = 11 mg/l (dampen)

606-047-00-9

2-benzyl-2-dimethylamino-4'-morfolinobutyrofenon

404-360-3

119313-12-1

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H410

606-152-00-X

(5-chloor-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenon

—

688046-61-9

Carc. 2

Aquatic Chronic 1

H351

H410

GHS08

GHS09

Wng

H351

H410

M = 1

607-177-00-9

tribenuron-methyl (ISO);

methyl-2-[N-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)-N-methylcarbamoylsulfamoyl]benzoaat

401-190-1

101200-48-0

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373

H317

H410

M = 100

M = 100

607-232-00-7

pyridaat (ISO);

O-(6-chloor-3-fenylpyridazine-4-yl) S-octylthiocarbonaat

259-686-7

55512-33-9

Acute Tox. 4

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H317

H400

H410

GHS07

GHS09

Wng

H302

H315

H317

H410

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 1

M = 10

607-247-00-9

dodecylmethacrylaat

205-570-6

142-90-5

STOT SE 3

H335

GHS07

Wng

H335

STOT SE 3; H335: C ≥ 10 %

607-256-00-8

azoxystrobin (ISO);

methyl-(E)-2-{2-[6-(2-cyaanfenoxy)pyrimidine-4-yloxy]fenyl-3-methoxyacrylaat

—

131860-33-8

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H331

H400

H410

GHS06

GHS09

Dgr

H331

H410

inademing:

ATE = 0,7 mg/l (stofdeeltjes of nevels)

M = 10

M = 10

607-314-00-2

ethofumesaat (ISO);

(RS)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-ylmethaansulfonaat;

247-525-3

26225-79-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

607-421-00-4

cypermethrin (ISO);

α-cyaan-3-fenoxybenzyl 3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaan-carboxylaat; cypermethrin cis/trans +/- 40/60

257-842-9

52315-07-8

Acute Tox. 4

Acute Tox. 4

STOT SE 3

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H335

H373 (zenuwstelsel)

H400

H410

GHS07

GHS08

GHS09

Wng

H332

H302

H335

H373 (zenuwstelsel)

H410

oraal; ATE = 500 mg/kg lichaamsgewicht

inademing; ATE = 3,3 mg/l (stofdeeltjes of nevels)

M = 100000

M = 100000

607-424-00-0

trifloxystrobin (ISO); methyl(E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluor-m-tolyl)ethylidwenaminooxy]-o-tolyl}acetaat

—

141517-21-7

Lact.

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H362

H317

H400

H410

GHS07

GHS09

Wng

H362

H317

H410

M = 100

M = 10

607-434-00-5

mecoprop-P (ISO) [1] en zouten daarvan;

(R)-2-(4-chloor-2-methylfenoxy)propionzuur [1] en zouten daarvan

240-539-0 [1]

16484-77-8 [1]

Acute Tox. 4

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS07

GHS05

GHS09

Dgr

H302

H318

H410

oraal: ATE = 431 mg/kg lichaamsgewicht

M = 10

M = 10

607-733-00-0

cyflumetofen (ISO);

2-methoxyethyl (RS)-2-(4-tert-butylfenyl)-2-cyaan-3-oxo-3-(α,α,α-trifluor-o-tolyl)propionaat

—

400882-07-7

Carc. 2

Skin Sens. 1A

H351

H317

GHS08

GHS07

Wng

H351

H317

607-737-00-2

diisohexylftalaat

276-090-2

71850-09-4

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-738-00-8

MCPA-thioëthyl (ISO);

S-ethyl-(4-chloor-2-methylfenoxy)ethaanthioaat; S-ethyl-4-chloor-o-tolyloxythioacetaat

246-831-4

25319-90-8

Acute Tox. 4

STOT RE. 2

Aquatic Acute 1 Aquatic Chronic 1

H302

H373 (lever)

H400

H410

GHS07

GHS08

GHS09

Wng

H302

H373 (lever)

H410

oraal: ATE = 450 mg/kg lichaamsgewicht

M = 10

M = 10

607-740-00-9

diisoöctylftalaat

248-523-5

27554-26-3

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-741-00-4

4-{[(6-chloorpyridine-3-yl)methyl](2,2-difluorethyl)amino}furan-2-(5H)-on; flupyradifuron

—

951659-40-8

Acute Tox. 4

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 (spier)

H400

H410

GHS07

GHS08

GHS09

Wng

H302

H373 (spier)

H410

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 10

M = 10

607-742-00-X

thiëncarbazone-methyl (ISO);

methyl-4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazool-1-yl)carbonylsulfamoyl]-5-methylthiofeen-3-carboxylaat

—

317815-83-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1000

M = 1000

607-743-00-5

L-(+)-melkzuur;

(2S)-2-hydroxypropaanzuur

201-196-2

79-33-4

Skin Corr. 1C

Eye Dam. 1

H314

H318

GHS05

Dgr

H314

EUH071

607-744-00-0

2-methoxyethylacrylaat

221-499-3

3121-61-7

Flam. Liq. 3

Muta. 2

Repr. 1B

Acute Tox. 3

Acute Tox. 4

Skin Corr. 1C

Eye Dam. 1

Skin Sens. 1

H226

H341

H360FD

H331

H302

H314

H318

H317

GHS02

GHS05

GHS06

GHS08

Dgr

H226

H341

H360FD

H331

H302

H314

H317

EUH071

inademing: ATE = 2,7 mg/l (dampen)

oraal: ATE = 404 mg/kg lichaamsgewicht

607-745-00-6

glyoxylzuur … %

206-058-5

298-12-4

Eye Dam. 1

Skin Sens. 1B

H318

H317

GHS05

GHS07

Dgr

H318

H317

B

607-746-00-1

natrium-N-(hydroxymethyl)glycinaat;

[formaldehyde dat vrijkomt uit natrium-N-(hydroxymethyl)glycinaat]

274-357-8

70161-44-3

Carc. 1B

Muta. 2

Acute Tox. 4

Acute Tox. 4

STOT SE 3

Skin Irrit. 2

Eye Irrit. 2

Skin Sens. 1

H350

H341

H332

H302

H335

H315

H319

H317

GHS08

GHS07

Dgr

H350

H341

H332

H302

H335

H315

H319

H317

inademing: ATE = 3 mg/l (stofdeeltjes of nevels)

oraal: ATE = 1100 mg/kg lichaamsgewicht

8

9

607-747-00-7

2,2-dibroom-2-cyaanaceetamide; [DBNPA]

233-539-7

10222-01-2

Acute Tox. 2

Acute Tox. 3

STOT RE 1

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H301

H372 (ademhalingswegen, inademing)

H315

H318

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H330

H301

H372 (ademhalingswegen, inademing)

H315

H318

H317

H410

inademing: ATE = 0,24 mg/l (stofdeeltjes of nevels)

oraal: ATE = 118 mg/kg lichaamsgewicht

M = 1

M = 1

607-748-00-2

[S-(Z,E)]-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-een-1-yl)-3-methylpenta-2,4-dieenzuur;

S-abscisinezuur

244-319-5

21293-29-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

607-749-00-8

methylsalicylaat

204-317-7

119-36-8

Repr. 2

Acute Tox. 4

Skin Sens. 1B

Aquatic Chronic 3

H361d

H302

H317

H412

GHS07

GHS08

Wng

H361d

H302

H317

H412

oraal: ATE = 890 mg/kg lichaamsgewicht

607-750-00-3

citroenzuur

201-069-1

77-92-9

Eye Irrit. 2

STOT SE 3

H319

H335

GHS07

Wng

H319

H335

607-751-00-9

ethametsulfuron-methyl (ISO);

methyl 2-({[4-ethoxy-6-(methylamino)-1,3,5-triazine-2-yl]carbamoyl}sulfamoyl)benzoaat

—

97780-06-8

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H400

H410

GHS07

GHS09

Wng

H319

H410

M = 1 000

M = 100

607-752-00-4

trinexapac-ethyl (ISO);

ethyl 4-[cyclopropyl(hydroxy)methyleen]-3,5-dioxocyclohexaancarboxylaat

—

95266-40-3

STOT RE 2

Skin Sens. 1B

Aquatic Chronic 1

H373 (spijsverteringskanaal)

H317

H410

GHS08

GHS07

GHS09

Wng

H373 (spijsverteringskanaal)

H317

H410

M = 1

607-753-00-X

(3aS,5S,6R,7aR,7bS,9aS,10R,12aS,12bS)-10-[(2S,3R,4R,5R)-3,4-dihydroxy-5,6-dimethylheptaan-2-yl]-5,6-dihydroxy-7a,9a-dimethylhexadecahydro-3H-benzo[c]indeno[5,4-e]oxepin-3-on; 24-epibrassinolide

—

78821-43-9

Aquatic Chronic 4

H413

H413

607-754-00-5

benzylsalicylaat

204-262-9

118-58-1

Skin Sens. 1B

H317

GHS07

Wng

H317

607-755-00-0

(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazool-5-yloxy}ethylmethylcarbonaat;

tolpyralaat

—

1101132-67-5

Carc. 2

Repr. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H361fd

H373 (oog)

H400

H410

GHS08

GHS09

Wng

H351

H361fd

H373 (oog)

H410

M = 10

M = 100

608-039-00-0

2-fenylhexaannitril

423-460-8

3508-98-3

Acute Tox. 4

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

oraal:

ATE = 500 mg/kg lichaamsgewicht

608-058-00-4

esfenvaleraat (ISO);

(S)-α-cyaan-3-fenoxybenzyl-(S)-2-(4-chloorfenyl)-3-methylbutyraat

—

66230-04-4

Acute Tox. 3

Acute Tox. 3

STOT SE 1

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H370 (zenuwstelsel)

H373

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H301

H370 (zenuwstelsel)

H373

H317

H410

oraal; ATE = 88,5 mg/kg lichaamsgewicht

inademing; ATE = 0,53 mg/l (stofdeeltjes of nevels)

M = 10 000

M = 10 000

608-069-00-4

fludioxonil (ISO); 4-(2,2-difluor-1,3-benzodioxool-4-yl)-1H-pyrrool-3-carbonitril

—

131341-86-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 10

609-041-00-4

2,4-dinitrofenol

200-087-7

51-28-5

Acute Tox. 3 *

Acute Tox. 3

Acute Tox. 2

STOT RE 1

Aquatic Acute 1

H331

H311

H300

H372

H400

GHS06

GHS08

GHS09

Dgr

H331

H311

H300

H372

H400

dermaal: ATE = 300 mg/kg lichaamsgewicht oraal: ATE = 30 mg/kg lichaamsgewicht

609-064-00-X

mesotrione (ISO);

2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexaandion

—

104206-82-8

Repr. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H373 (ogen, zenuwstelsel)

H400

H410

GHS08

GHS09

Wng

H361d

H373 (ogen, zenuwstelsel)

H410

M = 10

M = 10

611-181-00-6

kalium(oxido-NNO-azoxy)cyclohexaan;

cyclohexylhydroxydiazeen-1-oxide, kaliumzout;

[K‐HDO]

—

66603-10-9

Flam. Sol. 1

Acute Tox. 3

STOT RE 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H228

H301

H373 (lever)

H315

H318

H411

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H228

H301

H373 (lever)

H315

H318

H411

oraal: ATE = 136 mg/kg lichaamsgewicht

612-067-00-9

3-aminomethyl-3,5,5-trimethylcyclohexylamine

220-666-8

2855-13-2

Acute Tox. 4

Skin Corr. 1B

Eye Dam. 1

Skin Sens. 1A

H302

H314

H318

H317

GHS05

GHS07

Dgr

H302

H314

H317

oraal: ATE = 1 030 mg/kg lichaamsgewicht

Skin Sens. 1A; H317: C ≥ 0,001 %

612-252-00-4

imidacloprid (ISO);

(E)-1-(6-chloor-3-pyridylmethyl)-N-nitroimidazolidine-2-ylideenamine;

(2E)-1-[(6-chloorpyridine-3-yl) methyl]-N-nitroimidazolidine-2-imine

428-040-8

138261-41-3

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

oraal: ATE = 131 mg/kg lichaamsgewicht

M = 100

M = 1 000

612-294-00-3

mecetroniumetilsulfaat;

N-ethyl-N,N-dimethylhexadecaan-1-aminiumethylsulfaat;

mecetroniumethylsulfaat;

[MES]

221-106-5

3006-10-8

Skin Corr. 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H318

H400

H410

GHS05

GHS09

Dgr

H314

H410

EUH071

M = 100

M = 1000

613-048-00-8

carbendazim (ISO); methylbenzimidazool-2-ylcarbamaat

234-232-0

10605-21-7

Muta. 1B

Repr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H340

H360FD

H317

H400

H410

GHS07

GHS08

GHS09

Dgr

H340

H360FD

H317

H410

M = 10

M = 10

613-054-00-0

thiabendazool (ISO);

2-(thiazool-4-yl)benzimidazool

205-725-8

148-79-8

Aquatic Acute 1 Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

613-102-00-0

dimethomorf (ISO); (E,Z)-4-(3-(4-chloorfenyl)-3-(3,4-dimethoxyfenyl)acryloyl)morfoline

404-200-2

110488-70-5

Repr. 1B

Aquatic Chronic 2

H360F

H411

GHS08

GHS09

Dgr

H360F

H411

613-111-00-X

1,2,4-triazool

206-022-9

288-88-0

Repr. 1B

Acute Tox. 4

Eye Irrit. 2

H360FD

H302

H319

GHS08

GHS07

Dgr

H360FD

H302

H319

oraal: ATE = 1 320 mg/kg lichaamsgewicht

613-112-00-5

octhilinone (ISO);

2-octyl-2H-isothiazool-3-on; [OIT]

247-761-7

26530-20-1

Acute Tox. 2

Acute Tox. 3

Acute Tox. 3

Skin Corr. 1

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1 Aquatic Chronic 1

H330

H311

H301

H314

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H311

H301

H314

H317

H410

EUH071

inademing: ATE = 0,27 mg/l (stofdeeltjes of nevels)

dermaal: ATE = 311 mg/kg lichaamsgewicht oraal: ATE = 125 mg/kg lichaamsgewicht

Skin Sens. 1A; H317: C ≥ 0,0015 %

M = 100

M = 100

613-115-00-1

hymexazol (ISO);

3-hydroxy-5-methylisoxazool

233-000-6

10004-44-1

Repr. 2

Acute Tox. 4

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H361d

H302

H318

H317

H411

GHS08

GHS07

GHS05

GHS09

Dgr

H361d

H302

H318

H317

H411

oraal: ATE = 1600 mg/kg lichaamsgewicht

613-125-00-6

hexythiazox (ISO);

trans-5-(4-chloorfenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide

—

78587-05-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

613-166-00-X

flumioxazin (ISO);

N-(7-fluor-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazine-6-yl)cyclohex-1-een-1,2-dicarboximide

—

103361-09-7

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H400

H410

GHS08

GHS09

Wng

H361d

H410

M = 1 000

M = 1 000

613-202-00-4

pymetrozine (ISO);

(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleenamino)-1,2,4-triazine-3(2H)-on

—

123312-89-0

Carc. 2

Repr. 2

Aquatic Chronic 1

H351

H361fd

H410

GHS08

GHS09

Wng

H351

H361fd

H410

M = 1

613-208-00-7

imazamox (ISO);

(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazoline-2-yl)-5-methoxymethylnicotinezuur

—

114311-32-9

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H400

H410

GHS08

GHS09

Wng

H361d

H410

M = 10

M = 10

613-259-00-5

imiprothrin (ISO);

reactiemassa van: [2,4-dioxo-(2-propyn-1-yl)imidazolidine-3-yl]methyl(1R)-cis-chrysanthemaat; [2,4-dioxo-(2-propyn-1-yl)imidazolidine-3-yl]methyl(1R)-trans-chrysanthemaat;

428-790-6

72963-72-5

Carc. 2

Acute Tox. 4

Acute Tox. 4

STOT SE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H332

H302

H371 (zenuwstelsel, oraal, inademing)

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H332

H302

H371 (zenuwstelsel, oraal, inademing)

H410

inademing: ATE = 1,4 mg/l (stofdeeltjes of nevels)

oraal: ATE = 550 mg/kg lichaamsgewicht

M = 10

M = 10

613-267-00-9

thiamethoxam (ISO);

3-(2-chloor-thiazool-5-ylmethyl)-5-methyl[1,3,5]oxadiazinaan-4-ylideen-N-nitroamine

428-650-4

153719-23-4

Repr. 2

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H302

H400

H410

GHS07

GHS08

GHS09

Wng

H361fd

H302

H410

oraal: ATE = 780 mg/kg lichaamsgewicht

M = 10

M = 10

613-282-00-0

triticonazool (ISO);

(RS)-(E)-5-(4-chloorbenzylideen)-2,2-dimethyl-1-(1H-1,2,4-triazool-1-methyl)cyclopentanol

—

138182-18-0

Repr. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H361f

H373

H400

H410

GHS08

GHS09

Wng

H361f

H373

H410

M = 1

M = 1

613-329-00-5

halosulfuronmethyl (ISO);

methyl 3-chloor-5-{[(4,6-dimethoxypyrimidine-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazool-4-carboxylaat

—

100784-20-1

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H410

M = 1000

M = 1000

613-330-00-0

2-methylimidazool

211-765-7

693-98-1

Repr. 1B

H360Df

GHS08

Dgr

H360Df

613-331-00-6

(2RS)-2-[4-(4-chloorfenoxy)-2-(trifluormethyl)fenyl]-1-(1H-1,2,4-triazool-1-yl)propaan-2-ol;

mefentrifluconazool

—

1417782-03-6

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 1

M = 1

613-332-00-1

oxathiapiprolin (ISO);

1-(4-{4-[5-(2,6-difluorfenyl)-4,5-dihydro-1,2-oxazool-3-yl]-1,3-thiazool-2-yl}piperidine-1-yl)-2-[5-methyl-3-(trifluormethyl)-1H-pyrazool-1-yl]ethanon

—

1003318-67-9

Aquatic Chronic 1

H410

GHS09

Wng

H410

M = 1

613-333-00-7

pyrithionzink; (T-4)-bis[1-(hydroxy-κ-O)pyridine-2-(1H)-thionato-κ-S]zink

236-671-3

13463-41-7

Repr. 1B

Acute Tox. 2

Acute Tox. 3

STOT RE 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H330

H301

H372

H318

H400

H410

GHS08

GHS06

GHS05

GHS09

Dgr

H360D

H330

H301

H372

H318

H410

inademing: ATE = 0,14 mg/l (stofdeeltjes of nevels)

oraal: ATE = 221 mg/kg lichaamsgewicht

M = 1000

M = 10

613-334-00-2

flurochloridone (ISO);

3-chloor-4-(chloormethyl)-1-[3-(trifluormethyl)fenyl]pyrrolidine-2-on

262-661-3

61213-25-0

Repr. 1B

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360FD

H302

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H360FD

H302

H317

H410

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 100

M = 100

613-335-00-8

4,5-dichloor-2-octyl-2H-isothiazool-3-on; [DCOIT]

264-843-8

64359-81-5

Acute Tox. 2

Acute Tox. 4

Skin Corr. 1

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H314

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H302

H314

H317

H410

EUH071

inademing: ATE = 0,16 mg/l (stofdeeltjes of nevels)

oraal: ATE = 567 mg/kg lichaamsgewicht

Skin Irrit. 2; H315: 0,025 % ≤ C < 5 %

Eye Irrit. 2; H319: 0,025 % ≤ C < 3 %

Skin Sens. 1A; H317: C ≥ 0,0015 %

M = 100

M = 100

613-336-00-3

2-methyl-1,2-benzothiazool-3-(2H)-on;

[MBIT]

—

2527-66-4

Acute Tox. 4

Acute Tox. 3

Skin Corr. 1C

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 2

H312

H301

H314

H318

H317

H400

H411

GHS06

GHS05

GHS09

Dgr

H312

H301

H314

H317

H410

EUH071

dermaal: ATE = 1100 mg/kg lichaamsgewicht

oraal: ATE = 175 mg/kg lichaamsgewicht

Skin Sens. 1A; H317: C≥ 0,0015 %

M = 1

613-337-00-9

prothioconazool (ISO);

2-[2-(1-chloorcyclopropyl)-3-(2-chloorfenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazool-3-thion

—

178928-70-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

M = 1

613-338-00-4

azamethifos (ISO); S-[(6-chloor-2-oxooxazolo[4,5-b]pyridine-3(2H)-yl)methyl] O,O-dimethylthiofosfaat

252-626-0

35575-96-3

Carc. 2

Acute Tox. 3

Acute Tox. 4

STOT SE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H331

H302

H370 (zenuwstelsel)

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H331

H302

H370 (zenuwstelsel)

H317

H410

inademing: ATE = 0,5 mg/l (stofdeeltjes of nevels)

oraal: ATE = 500 mg/kg lichaamsgewicht

M = 1 000

M = 1 000

613-339-00-X

3-methylpyrazool

215-925-7

1453-58-3

Repr. 1B

Acute Tox. 4

STOT RE 2

Skin Corr. 1

Eye Dam. 1

H360D

H302

H373 (longen)

H314

H318

GHS08

GHS07

GHS05

Dgr

H360D

H302

H373 (longen)

H314

oraal: ATE = 500 mg/kg lichaamsgewicht

613-340-00-5

clomazon (ISO); 2-(2-chloorbenzyl)-4,4-dimethyl-1,2-oxazolidine-3-on

—

81777-89-1

Acute Tox. 4

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H400

H410

GHS07

GHS09

Wng

H332

H302

H410

inademing: ATE = 4,85 mg/l (stofdeeltjes of nevels)

oraal: ATE = 768 mg/kg lichaamsgewicht

M = 1

M = 1

614-030-00-2

emamectinebenzoaat (ISO); (4”R)-4”-deoxy-4”-(methylamino)avermectine B1 benzoaat

—

155569-91-8

Acute Tox. 3

Acute Tox. 3

Acute Tox. 3

STOT SE 1

STOT RE 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H370 (zenuwstelsel)

H372 (zenuwstelsel)

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H331

H311

H301

H370 (zenuwstelsel)

H372 (zenuwstelsel)

H318

H410

inademing:

ATE = 0,663 mg/l

(stofdeeltjes of nevels)

dermaal:

ATE = 300 mg/kg

lichaamsgewicht

oraal: ATE =60 mg/kg

lichaamsgewicht

STOT RE 1; H372: C ≥ 5 %; STOT RE 2; H373: 0,5 % ≤ C < 5 %

M = 10 000

M = 10 000

616-014-00-0

butanonoxim; ethylmethylketoxim; ethylmethylketonoxim

202-496-6

96-29-7

Carc. 1B

Acute Tox. 4

Acute Tox. 3

STOT SE 3

STOT SE 1

STOT RE 2

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H350

H312

H301

H336

H370 (bovenste luchtwegen)

H373 (bloed)

H315

H318

H317

GHS08

GHS06

GHS05

Dgr

H350

H312

H301

H336

H370 (bovenste luchtwegen)

H373 (bloed)

H315

H318

H317

dermaal: ATE = 1100 mg/kg lichaamsgewicht oraal: ATE = 100 mg/kg lichaamsgewicht

616-018-00-2

diëthyltoluamide (ISO): N,N-diëthyl-m-toluamide; [deet]

205-149-7

134-62-3

Acute Tox. 4

Skin Irrit. 2

Eye Irrit. 2

H302

H315

H319

GHS07

Wng

H302

H315

H319

oraal:

ATE = 1892 mg/kg lichaamsgewicht

616-032-00-9

diflufenican (ISO);

N-(2,4-difluorfenyl)-2-[3-(trifluormethyl)fenoxy]-3-pyridinecarboxamide; 2′,4′-difluor-2-(α,α,α-trifluor-m-tolyloxy)nicotinanilide

—

83164-33-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10 000

M = 1 000

616-106-00-0

fenmedifam (ISO); methyl 3-(3-methylcarbaniloyloxy)carbanilaat

237-199-0

13684-63-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

M = 10

616-113-00-9

desmedifam (ISO);

ethyl-3-fenylcarbamoyloxyfenylcarbamaat

237-198-5

13684-56-5

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d

H400

H410

GHS08

GHS09

Wng

H361d

H410

M = 10

M = 10

616-225-00-8

(RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]aceetamide; mandestrobine

—

173662-97-0

Aquatic Acute 1 Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 10

616-226-00-3

carboxine (ISO);

2-methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide; 5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxanilide

226-031-1

5234-68-4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 (nieren)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 (nieren)

H317

H410

M = 1

M = 1

616-227-00-9

metaflumizon (ISO); (EZ)-2'-[2-(4-cyaanfenyl)-1-(α,α,α-trifluor-m-tolyl)ethylideen]-[4-(trifluormethoxy)fenyl]carbanilohydrazide [E-isomeer ≥ 90 %, Z-isomeer ≤ 10 % relatief gehalte] [1];

(E)-2'-[2-(4-cyaanfenyl)-1-(α,α,α-trifluor-m-tolyl)ethylideen]-[4-(trifluormethoxy)fenyl]carbanilohydrazide [2]

—

139968-49-3 [1]

852403-68-0 [2]

Repr. 2

Lact.

STOT RE 2

H361fd

H362

H373

GHS08

Wng

H361fd

H362

H373

616-228-00-4

3-(difluormethyl)-1-methyl-N-(3”,4”,5'-trifluorbifenyl-2-yl)pyrazool-4-carboxamide;

fluxapyroxad

—

907204-31-3

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H362

H400

H410

GHS09

Wng

H362

H410

M = 1

M = 1

616-230-00-5

N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA]

213-103-2

924-42-5

Carc. 1B

Muta. 1B

STOT RE 1

H350

H340

H372 (perifeer zenuwstelsel)

GHS08

Dgr

H350

H340

H372 (perifeer zenuwstelsel)

616-231-00-0

5-fluor-1,3-dimethyl-N-[2-(4-methylpentaan-2-yl)fenyl]-1-H-pyrazool-4-carboxamide; 2’-[(RS)-1,3-dimethylbutyl]-5-fluor-1,3-dimethylpyrazool-4-carboxanilide;

penflufen

—

494793-67-8

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 1

M = 1

616-232-00-6

iprovalicarb (ISO);

isopropyl [(2S)-3-methyl-1-{[1-(4-methylfenyl)ethyl]amino}-1-oxobutaan-2-yl]carbamaat

—

140923-17-7

Carc. 2

H351

GHS08

Wng

H351

616-233-00-1

silthiofam (ISO);

N-allyl-4,5-dimethyl-2-(trimethylsilyl)thiofeen-3-carboxamide

—

175217-20-6

STOT RE 2

Aquatic Chronic 2

H373

H411

GHS08

GHS09

Wng

H373

H411

616-234-00-7

N-methoxy-N-[1-methyl-2-(2,4,6-trichloorfenyl)-ethyl]-3-(difluormethyl)-1-methylpyrazool-4-carboxamide; pydiflumetofen

—

1228284-64-7

Carc. 2

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H361f

H400

H410

GHS08

GHS09

Wng

H351

H361f

H410

M = 1

M = 1

616-235-00-2

N-{2-[[1,1’-bi(cyclopropyl)]-2-yl]fenyl}-3-(difluormethyl)-1-methyl-1H-pyrazool-4-carboxamide; sedaxaan

—

874967-67-6

Carc. 2

Aquatic Acute 1

Aquatic Chronic 2

H351

H400

H411

GHS08

GHS09

Wng

H351

H410

M = 1

617-006-00-X

bis(α,α-dimethylbenzyl)peroxide

201-279-3

80-43-3

Org. Perox. F

Repr. 1B

Skin Irrit. 2

Eye Irrit. 2

Aquatic Chronic 2

H242

H360D

H315

H319

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H242

H360D

H315

H319

H411

648-055-00-5

pek, koolteer, hoge temperatuur; [het residu dat wordt verkregen bij de destillatie van hogetemperatuurkoolteer. Het is een zwarte vaste stof met een verwekingstraject van ongeveer 30 °C tot 180 °C (86 °F tot 356 °F). Bestaat voornamelijk uit een complex mengsel van aromatische koolwaterstoffen met drie- of meervoudig gecondenseerde ringen.]

266-028-2

65996-93-2

Carc. 1A

Muta. 1B

Repr. 1B

H350

H340

H360FD

GHS08

Dgr

H350

H340

H360FD

650-056-00-0

dibutylbis(pentaan-2,4-dionato-O,O”)tin

245-152-0

22673-19-4

Repr. 1B

STOT RE 1

H360FD

H372 (immuunsysteem)

GHS08

Dgr

H360FD

H372 (immuunsysteem)

650-057-00-6

margosa-extract [koudgeperste olie van zaden van Azadirachta indica zonder dop, geëxtraheerd met superkritisch koolstofdioxide]

283-644-7

84696-25-3

Aquatic Chronic 3

H412

H412